We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XOXO
576
DELISTED
Xo Group Inc
XOXO
| $2.13M | 0.01% |
173,897
+17,444
| +11% | +$194K |
|
577
MaxLinear
MXL
$6.66B
| $2.12M | 0.01% |
210,419
+33,075
| +19% | +$303K |
|
578
Natural Gas Services Group
NGS
$463M
| $2.11M | 0.01% |
63,907
+18,530
| +41% | +$575K |
|
579
News Corp Class B
NWS
$17.9B
| $2.11M | 0.01% |
120,997
-121,005
| -50% | -$2.04M |
|
580
A.O. Smith
AOS
$8.69B
| $2.1M | 0.01% |
84,876
+22,202
| +35% | +$533K |
|
581
Analog Devices
ADI
$190B
| $2.1M | 0.01% |
+38,801
| New | +$2.05M |
|
|
NJ
582
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $2.09M | 0.01% |
136,052
-146,232
| -52% | -$2.13M |
|
|
VRE
583
DELISTED
Veris Residential
VRE
| $2.07M | 0.01% |
96,420
-19,364
| -17% | -$409K |
|
584
Adtran
ADTN
$615M
| $2.06M | 0.01% |
91,463
-155,134
| -63% | -$3.51M |
|
585
Acco Brands
ACCO
$408M
| $2.06M | 0.01% |
320,667
-40,561
| -11% | -$248K |
|
586
ONE Gas
OGS
$5.02B
| $2.05M | 0.01% |
54,222
-5,523
| -9% | -$202K |
|
|
LNCE
587
DELISTED
Snyders-Lance, Inc.
LNCE
| $2.04M | 0.01% |
77,080
-1,346
| -2% | -$36.2K |
|
588
KLA
KLAC
$259B
| $2.02M | 0.01% |
+277,860
| New | +$1.84M |
|
589
Ingles Markets
IMKTA
$1.64B
| $1.98M | 0.01% |
75,024
-26,888
| -26% | -$686K |
|
|
ARGO
590
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.97M | 0.01% |
+53,513
| New | +$1.82M |
|
|
CBB
591
DELISTED
Cincinnati Bell Inc.
CBB
| $1.96M | 0.01% |
99,881
+60,808
| +156% | +$1.11M |
|
|
VG
592
DELISTED
Vonage Holdings Corporation
VG
| $1.96M | 0.01% |
522,779
-473,468
| -48% | -$1.79M |
|
593
Kosmos Energy
KOS
$1.47B
| $1.95M | 0.01% |
+173,282
| New | +$1.85M |
|
|
NPKI
594
NPK International
NPKI
$1.13B
| $1.94M | 0.01% |
155,451
+80,094
| +106% | +$934K |
|
595
Packaging Corp of America
PKG
$22.9B
| $1.93M | 0.01% |
27,052
-69,576
| -72% | -$4.78M |
|
596
Avista
AVA
$3.25B
| $1.93M | 0.01% |
57,620
-1,936
| -3% | -$61.3K |
|
|
DNB
597
DELISTED
Dun & Bradstreet
DNB
| $1.93M | 0.01% |
+17,514
| New | +$1.84M |
|
598
HNI Corp
HNI
$3.62B
| $1.93M | 0.01% |
49,307
-22,167
| -31% | -$810K |
|
599
Anika Therapeutics
ANIK
$275M
| $1.93M | 0.01% |
41,539
+30,737
| +285% | +$1.37M |
|
600
Commerce Bancshares
CBSH
$8.5B
| $1.92M | 0.01% |
+74,207
| New | +$1.84M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.